US FDA Mulls Standards For Neurodiagnostic Tools
This article was originally published in Clinica
Medical devices to diagnose Alzheimer’s and other neurological or psychological problems hold a great deal of promise, but validating their benefits for patients remains a pressing concern.
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.